LinkedIn Icon 
31 October – 2 November , 2017

London, UK




  • Past Presentations Pack

    Optimizing the Scalability of Gene Therapy Manufacturing
     – Lance Weed, VP, Operations, uniQure

    Clinical Development of Gene Therapy for Rare Diseases
     – Lei Xu, Chief General Medicine Branch 2, Division of Clinical Evaluation & Pharmacology Toxicology, OTAT, CBER FDA